ArticleTransfusion2018
Improving quality of care for patients with iron deficiency anemia presenting to the emergency department.
Article in Transfusion, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05304442 (Intravenous Ferric Derisomaltose for Moderate to Severe Anemia Due to Uterine Bleeding in the Emergency Department), which is not on this map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Intravenous Ferric Derisomaltose for Moderate to Severe Anemia Due to Uterine Bleeding in the Emergency Department: a Randomized Trial
Who cites it
13 citing papers in PubMed, 29 citations in OpenAlex.
- Utilization of Intravenous Iron Therapy and Red Blood Cell Transfusion in Emergency Department Patients with Anemia: A Single-Center Retrospective Cohort Study.Journal of clinical medicine · 2026Article
- Article
- Standardizing the evaluation and management of iron deficiency anemia secondary to heavy menstrual bleeding in the emergency department.Pediatric blood & cancer · 2024Article
- Article
- Impact of iron supplementation on patient outcomes for women with abnormal uterine bleeding: a protocol for a systematic review and meta-analysis.Systematic reviews · 2023Article
- A synchronized approach between emergency department and anemia clinic to intravenous iron treatment for very severe (Hb <7.0 g/dL) and extreme (<5.0 g/dL) iron-deficiency anemia: short-, medium- and long-term efficacy and safety analysis.Blood transfusion = Trasfusione del sangue · 2023Article
- Severe iron deficiency anemia in the paediatric emergency department: A retrospective study.Paediatrics & child health · 2023Article
- Choosing Wisely® in Hematology: Have We Made a Difference?Current hematologic malignancy reports · 2020Review
- Essential Role of Patient Blood Management in a Pandemic: A Call for Action.Anesthesia and analgesia · 2020Review
- Treatment with ferric carboxymaltose in stable patients with severe iron deficiency anemia in the emergency department.Internal and emergency medicine · 2020Article
- Sparing unnecessary transfusions through patient blood management: time for application also in internal and emergency medicine.Internal and emergency medicine · 2020Article
- Early intravenous iron administration in the Emergency Department reduces red blood cell unit transfusion, hospitalisation, re-transfusion, length of stay and costs.Blood transfusion = Trasfusione del sangue · 2020Article
- Evidence-Based Minireview: The role of IV iron in management of patients with iron-deficiency anemia presenting to the emergency department.Hematology. American Society of Hematology. Education Program · 2019Review
Corrections and comments
- Commented on by
Authors and funding
4 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPatients presenting to the emergency department (ED) with iron deficiency anemia (IDA) are underrecognized, undertreated with iron, and overtransfused. A 3-month audit of red blood cell (RBC) transfusions at the Sunnybrook Health Sciences Centre ED in 2013 showed that only 53% of transfusions for IDA were appropriate. The aim of this quality improvement project was to increase the rate of appropriate transfusion to greater than 80%. STUDY DESIGN AND
methodsSince November 2013, several quality improvement interventions have been implemented, including educational presentations, development of an algorithm on IDA management in the ED, and development of an ED IDA toolkit. The primary outcome was appropriateness of RBC transfusions per month. The process measure was monthly intravenous (IV) iron use in IDA patients managed exclusively by ED staff. Balancing measures included IV iron use according to the algorithm and undertransfusion.
resultsOver a 24-month period beginning January 2014, assessment of 193 units transfused in the ED showed an improvement of RBC appropriateness to 91% (range 50%-100%). IV iron use increased from one dose in the 3-month audit to an average of 2.6 and 4.7 per month in 2014 and 2015, respectively. IV iron use did not follow the algorithm in 19% (18 of 93) of cases: 12 were given to patients with less severe iron deficiency or bleeding.
conclusionImproved RBC transfusion appropriateness for IDA in the ED can be achieved and maintained with the implementation of simple educational and practical interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.